GlassScriptPhysician profile
Young Ha Lee
NPI 1881984391
$2,439.12
in general payments reported to CMS, 2019-2025
16 companies · $919 in 2025
The $919 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.00 · 2021: $170 · 2022: $192 · 2023: $174 · 2024: $893 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,887 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.33 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $482.99 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $367.91 | 2024-2025 | Tremfya |
| Pfizer INC. | $299.32 | 2022-2025 | |
| Incyte Corporation | $295.99 | 2021-2025 | Opzelura |
| Genzyme Corporation | $154.85 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.64 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $136.95 | 2024-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $107.25 | 2024-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $99.12 | 2024-2025 | Zoryve |
| Celgene Corporation | $91.00 | 2019 | |
| Amgen INC. | $78.10 | 2024-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $68.39 | 2023-2024 | Sotyktu |
| Organon LLC | $34.02 | 2025 | Vtama |
| Abbvie INC. | $31.13 | 2024 | |
| Galderma Laboratories, L.P. | $27.56 | 2025 | Nemluvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.90 | 2024 | Olumiant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.